Connection
Rangaswamy Govindarajan to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Rangaswamy Govindarajan has written about Antineoplastic Combined Chemotherapy Protocols.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.549 |
|
|
|
-
Govindarajan R, Siegel E, Makhoul I, Williamson S. Bevacizumab and erlotinib in previously untreated inoperable and metastatic hepatocellular carcinoma. Am J Clin Oncol. 2013 Jun; 36(3):254-7.
Score: 0.293
-
Govindarajan R. Irinotecan/thalidomide in metastatic colorectal cancer. Oncology (Williston Park). 2002 Apr; 16(4 Suppl 3):23-6.
Score: 0.135
-
Algazi AP, Othus M, Daud AI, Lo RS, Mehnert JM, Truong TG, Conry R, Kendra K, Doolittle GC, Clark JI, Messino MJ, Moore DF, Lao C, Faller BA, Govindarajan R, Harker-Murray A, Dreisbach L, Moon J, Grossmann KF, Ribas A. Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Nat Med. 2020 10; 26(10):1564-1568.
Score: 0.122